Proton Capital Enters Into Agreement to Purchase PharmaChoice Canada Branded Pharmacy In Saskatoon For Proposed Qualifying Transaction
Retrieved on:
Thursday, February 22, 2024
Earnout, Issuer, News, Growth, Edinburgh Business School, Saint, Acquisition, Commerce, Sale, St. Francis Xavier University, Indian stock exchange, University, CPC, PharmaChoice, Offering, Target, Physics, Toronto Stock Exchange, Medication, Pharmacist, Outline of health sciences, Qualification, CMA, McKesson Corporation, Partnership, CPA, Mylan, McDonald House, Transaction, Employment, United, Chair, Federated, Cannabis, Prospectus, BBA, Honor, Marketing, Bookrunner, Food, Bachelor, Audit committee, Executive, SaskTel, All Saints, Security (finance)
The Share Purchase Agreement provides that Proton will purchase 75% of the issued and outstanding shares of the Target Pharmacy.
Key Points:
- The Share Purchase Agreement provides that Proton will purchase 75% of the issued and outstanding shares of the Target Pharmacy.
- The Qualifying Transaction will not constitute a Non-Arm’s Length Qualifying Transaction (as such term is defined in the policies of the TSXV).
- The parties to the Qualifying Transaction are at arm’s length and therefore the approval of the shareholders of Proton in respect of the Qualifying Transaction will not be required.
- The Prospectus will contain important detailed information about the Corporation, the Qualifying Transaction and the proposed Offering.